Dressman et al. [25] have demonstrated that Src pathway activity is associated with chemotherapy response because of a significant correlation between the activation of Src pathway and poor prognosis in patients with platinum-resistant ovarian cancer. The gene discussed is SRC; the disease is ovarian cancer.